# Study of JMKX003948 Ophthalmic Suspension in Healthy Participants

> **NCT06832657** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Jemincare** · enrollment: 40 (estimated)

## Conditions studied

- Age-Related Macular Degeneration (AMD)
- Diabetic Macular Edema (DME)

## Interventions

- **DRUG:** JMKX003948 Ophthalmic Suspension
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06832657
- **Lead sponsor:** Jemincare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06832657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06832657, "Study of JMKX003948 Ophthalmic Suspension in Healthy Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06832657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*